Outcomes of Endoscopic Submucosal Dissection for Treatment of Superficial Pharyngeal Cancers: Systematic Review and Meta-Analysis.

Faisal Kamal, Muhammad Ali Khan, Wade Lee-Smith, Sachit Sharma, Zaid Imam, Dawit Jowhar, Ellen Petryna, Julia Esswein, Ashu Acharya, Muhammad Aziz, Umer Farooq, Usman Zafar, Stephanie Mcdonough, Douglas G Adler

Journal: Digestive diseases and sciences 2022;67(8):3518-3528

PMID: 34505257

Abstract

BACKGROUND AND AIMS

Studies evaluating the role of endoscopic submucosal dissection (ESD) in the management of superficial pharyngeal cancers have reported promising results. This meta-analysis evaluates the efficacy and safety of ESD in the management of superficial pharyngeal cancers.

METHODS

We reviewed several databases from inception to September 03, 2020, to identify studies evaluating the efficacy and safety of ESD in the management of superficial pharyngeal cancers. Our outcomes of interest were en bloc resection rate, complete resection rate, adverse events, and rates of local recurrence. Pooled rates with 95% confidence intervals (CI) for all outcomes were calculated using random-effect model. Heterogeneity was assessed by I statistic. We assessed publication bias by using funnel plots and Egger's test. We conducted meta-regression analysis to explore heterogeneity in analyses.

RESULTS

Ten studies were included in analyses. All studies were from Asia. Pooled rates (95% CI) for en bloc resection and complete resection were 94% (87%, 97%) and 72% (62%, 80%), respectively. The pooled rates (95% CI) for adverse events and local recurrence were 10% (5%, 17%) and 1.9% (0.9%, 4%), respectively. Most of the analyses were limited by substantial heterogeneity. On meta-regression analysis, the heterogeneity was explained by size of tumor and histology. Funnel plots and Egger's test showed no evidence of publication bias.

CONCLUSIONS

This meta-analysis including studies from Asian countries demonstrated that ESD is an efficacious and safe option in the management of superficial pharyngeal cancers. More studies and studies from Western countries are needed to further validate these findings.

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Address: Division of Gastroenterology, University of Tennessee Health Science Center, Memphis, TN, USA.; Department of Gastroenterology, Hepatology and Nutrition, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mulford Health Sciences Library, University of Toledo, Toledo, OH, USA.; Department of Medicine, University of Toledo, Toledo, OH, USA.; Division of Gastroenterology, William Beaumont Hospital, Royal Oak, MI, USA.; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.; Division of Gastroenterology, University of Toledo, Toledo, OH, USA.; Department of Medicine, Loyola Medicine/MacNeal Hospital, Berwyn, IL, USA.; Department of Medicine, Lehigh Valley Health Network, Allentown, PA, USA.; Division of Gastroenterology, University of Utah, Salt Lake City, UT, USA.; Center for Advanced Therapeutic Endoscopy (CATE), Porter Adventist Hospital, 2525 S Downing St, Denver, CO, 80210, USA. [email protected].

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.